Generation of a DAPK1 knockout first (conditional ready) human embryonic stem cell line (ZSSYe001-A) by CRISPR-Cas9 technology

被引：3

作者：

Xu, Cancan ^{[2
,3
]}

Zhou, Zhuowei ^{[1
]}

Liu, Chang ^{[1
]}

Kang, Xinmei ^{[1
]}

Zhong, Xiaofen ^{[3
]}

Zhang, Qi ^{[1
]}

Xu, Yan ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 3, Biotherapy Ctr, Guangzhou 510630, Peoples R China

[2] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Peoples R China

[3] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou 510530, Peoples R China

来源：

STEM CELL RESEARCH | 2020年 / 43卷

基金：

中国国家自然科学基金;

关键词：

D O I：

10.1016/j.scr.2019.101693

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Death-associated protein kinase 1 (DAPK1) is a Ca2+/calmodulin regulated Ser/Thr kinase involved in various cellular processes including cell death, autophagy and inflammation. Its dysregulation has been linked to tumour metastasis, anti-viral responses, Alzheimer's disease and other neurological disorders. To further investigate the role of DAPK1 in these processes, we generated a DAPK1 knockout first (conditional ready) human embryonic stem (hES) cell line in which the endogenous DAPK1 can be easily restored with expression of FLPe. This cell line provides an ideal model to study the role of DAPK1 in human development and various pathologies related to DAPK1 dysregulation in vitro.

引用

页数：5

共 50 条

[31] Generation of a TSC2 knockout embryonic stem cell line by CRISPR/ Cas9 editing
Zhang, Siyao
Fan, Jiaqi
Sun, Hairui
Hao, Xiaoyan
He, Yihua
STEM CELL RESEARCH, 2024, 77
[32] Generation of myoglobin (MB)-knockout human embryonic stem cell (hESC) line (KAIMRCe002-A-1S) using CRISPR/Cas9 technology
Alowaysi, Maryam
Al-Shehri, Mohammad
Baadhaim, Moayad
AlZahrani, Hajar
Aboalola, Doaa
Daghestani, Mustafa
Hashem, Heba
Aljahdali, Rawan
Salem, Rayan
Alharbi, Adel
Muharraq, Mohammed
Alghamdi, Khaled
Alsobiy, Fawaz
Zia, Asima
Lehmann, Robert
Tegner, Jesper
Alsayegh, Khaled
STEM CELL RESEARCH, 2023, 71
[33] Generation of a Bag1 homozygous knockout mouse embryonic stem cell line using CRISPR/Cas9
Tang, Cheng-cheng
Shan, Li Pik
Wang, Wu-ming
Lu, Gang
Tare, Rahul S.
Lee, Kenneth Ka Ho
STEM CELL RESEARCH, 2017, 21 : 29 - 31
[34] Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system
Romano, Elena
Trionfini, Piera
Giampietro, Roberta
Benigni, Ariela
Tomasoni, Susanna
STEM CELL RESEARCH, 2021, 57
[35] Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing
Getachew, Anteneh
Yang, Zhen
Huang, Xinping
Wu, Feima
Liu, Yan Ying
Yan, Chen
Yang, Fan
Li, Yinxiong
STEM CELL RESEARCH, 2021, 54
[36] Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system
Zhang, Wang
Li, Yuming
Wang, Li
Xin, Tao
Zhang, Canwei
STEM CELL RESEARCH, 2021, 57
[37] Generation of Sigmar1 conditional knockout mouse using CRISPR-Cas9 gene targeting
Huang, Liang
Xiao, Haiyan
Xie, Xiaoling
Hu, Fang
Tang, Fulei
Smith, Sylvia B.
Gan, Lin
GENESIS, 2022, 60 (6-7)
[38] CRISPR/Cas9-mediated generation of a homozygous CBR2 knockout H1 human embryonic stem cell line
Zhang, Lei
Zhang, Fengfeng
Yao, Mingze
STEM CELL RESEARCH, 2025, 84
[39] Generation of an ASGR1 homozygousmutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9
Xu, Yingying
Wu, Yuhang
Guo, Dongsheng
Gao, Ge
Lai, Keyu
Yang, Fan
Wang, Kepin
Wu, Han
Lai, Liangxue
Li, Jialiang
Xu, Kecheng
Li, Yin-Xiong
STEM CELL RESEARCH, 2017, 22 : 29 - 32
[40] Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system
Luo, Qian
Wei, Cong
Long, Yan
Zhang, Meng
Shan, Wei
Li, Honghu
Cai, Shuyang
Xu, Yulin
Qian, Pengxu
Huang, He
STEM CELL RESEARCH, 2021, 53

← 1 2 3 4 5 →